NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently appointed Glenn Tyson as its first chief commercial officer as the company prepares for anticipated regulatory milestones tied to its ketamine-based …
NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer Read More